AlphaCrest Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$1.38M Sell
2022
Q2
$1.92M Sell
2022
Q1
$4.36M Buy
2021
Q4
$2.03M Sell
2021
Q3
$1.91M Buy
2021
Q2
$631K Sell
2021
Q1
$4.07M Buy
2020
Q4
$2.81M Buy
2020
Q3
$1.22M Buy
2020
Q2
$247K Sell
2020
Q1
$493K Sell
2019
Q4
$797K Sell
2019
Q3
$1.85M Sell
2019
Q2
$2.62M Buy
2019
Q1
$1.2M Buy
2018
Q4
$550K Buy